Key Financial Data Of Reporting Company

Medrx Co.,Ltd. - Filing #7593851

Concept 2022-01-01 to
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-06-30
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-06-30
2021-01-01 to
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
9,482,000 JPY
8,350,000 JPY
7,485,000 JPY
Ordinary profit (loss)
-382,264,000 JPY
-1,066,450,000 JPY
-475,809,000 JPY
Net assets
1,579,054,000 JPY
1,955,493,000 JPY
1,989,456,000 JPY
Total assets
1,696,432,000 JPY
2,108,589,000 JPY
2,690,259,000 JPY
Basic earnings (loss) per share
-15.50
-7.49
-49.62
-23.94
-10.59
Diluted earnings per share
Equity-to-asset ratio
0.895 xbrli:pure
0.899 xbrli:pure
0.717 xbrli:pure
Net cash provided by (used in) operating activities
-437,904,000 JPY
-923,688,000 JPY
-424,174,000 JPY
Net cash provided by (used in) investing activities
-618,000 JPY
-2,542,000 JPY
-1,410,000 JPY
Net cash provided by (used in) financing activities
280,000 JPY
815,915,000 JPY
864,330,000 JPY
Cash and cash equivalents
1,269,049,000 JPY
1,703,644,000 JPY
2,252,580,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.